Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)
Clinical trial NCT00836927 · TERMINATED
Trial details
- NCT number
- NCT00836927
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2017-04-03
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.